Literature DB >> 22177689

New directions in the basic and translational biology of interleukin-27.

Elia D Tait Wojno1, Christopher A Hunter.   

Abstract

Interleukin (IL)-27 is a member of the IL-6 and IL-12 family composed of the IL-27p28 and Epstein-Barr virus-induced gene 3 (EBI3) subunits. Although IL-27 was originally identified as a proinflammatory factor, subsequent studies have revealed the pleiotropic nature of this cytokine. This review discusses recent work that has explored the effect of IL-27 on CD4(+) T cell subsets, including T regulatory type 1 (Tr-1) cells, T follicular helper cells (Tfhs), and forkhead box P3 (Foxp3)(+) T regulatory cells (Tregs). Additionally, we highlight studies that have identified a role for the IL-27p28 subunit as a cytokine receptor antagonist. Much of the recent work on IL-27 has been relevant to human disease states characterized by inappropriate or excessive inflammation, and this review discusses potential opportunities to use IL-27 as a therapeutic agent.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22177689      PMCID: PMC3273610          DOI: 10.1016/j.it.2011.11.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  108 in total

1.  Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin.

Authors:  O Devergne; M Birkenbach; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  No inhibition of IL-27 signaling by soluble gp130.

Authors:  Jürgen Scheller; Björn Schuster; Christoph Hölscher; Takayuki Yoshimoto; Stefan Rose-John
Journal:  Biochem Biophys Res Commun       Date:  2005-01-28       Impact factor: 3.575

3.  The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.

Authors:  Shanjin Cao; Jianguo Liu; Lihua Song; Xiaojing Ma
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

4.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.

Authors:  A Hutloff; A M Dittrich; K C Beier; B Eljaschewitsch; R Kraft; I Anagnostopoulos; R A Kroczek
Journal:  Nature       Date:  1999-01-21       Impact factor: 49.962

5.  IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.

Authors:  Rosalba Salcedo; Jimmy K Stauffer; Erin Lincoln; Timothy C Back; Julie A Hixon; Cynthia Hahn; Kimberly Shafer-Weaver; Anatoli Malyguine; Robert Kastelein; Jon M Wigginton
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

Review 6.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

7.  Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.

Authors:  David Artis; Leanne M Johnson; Karen Joyce; Christiaan Saris; Alejandro Villarino; Christopher A Hunter; Phillip Scott
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

8.  Potent antitumor activity of interleukin-27.

Authors:  Masayuki Hisada; Sadahiro Kamiya; Koji Fujita; Maria Laura Belladonna; Tatuya Aoki; Yasuhisa Koyanagi; Junichiro Mizuguchi; Takayuki Yoshimoto
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  Induction of IgG2a class switching in B cells by IL-27.

Authors:  Takayuki Yoshimoto; Keiko Okada; Noriko Morishima; Sadahiro Kamiya; Toshiyuki Owaki; Masayuki Asakawa; Yoichiro Iwakura; Fumio Fukai; Junichiro Mizuguchi
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

10.  CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.

Authors:  Ann E Herman; Gordon J Freeman; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  48 in total

Review 1.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

Review 2.  IL-12 family cytokines: immunological playmakers.

Authors:  Dario A A Vignali; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-07-19       Impact factor: 25.606

3.  Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults.

Authors:  Hector R Wong; Kathleen D Liu; Kirsten N Kangelaris; Patrick Lahni; Carolyn S Calfee
Journal:  J Crit Care       Date:  2014-04-18       Impact factor: 3.425

Review 4.  Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment.

Authors:  Mary Sandquist; Hector R Wong
Journal:  Expert Rev Clin Immunol       Date:  2014-08-21       Impact factor: 4.473

Review 5.  Emerging infection and sepsis biomarkers: will they change current therapies?

Authors:  Lauren Jacobs; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-17       Impact factor: 5.091

6.  Interruption of macrophage-derived IL-27(p28) production by IL-10 during sepsis requires STAT3 but not SOCS3.

Authors:  Markus Bosmann; Norman F Russkamp; Birgit Strobl; Julian Roewe; Liza Balouzian; Florence Pache; Markus P Radsak; Nico van Rooijen; Firas S Zetoune; J Vidya Sarma; Gabriel Núñez; Mathias Müller; Peter J Murray; Peter A Ward
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

Review 7.  Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?

Authors:  Mairi H McLean; Markus F Neurath; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

8.  Oral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27.

Authors:  Irina Kochetkova; Theresa Thornburg; Gayle Callis; Kathryn Holderness; Massimo Maddaloni; David W Pascual
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

Review 9.  Possible roles of IL-12-family cytokines in rheumatoid arthritis.

Authors:  Richard M Pope; Shiva Shahrara
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

10.  Effect of pulsed electromagnetic field (PEMF) on infarct size and inflammation after cerebral ischemia in mice.

Authors:  Juan Carlos Pena-Philippides; Yirong Yang; Olga Bragina; Sean Hagberg; Edwin Nemoto; Tamara Roitbak
Journal:  Transl Stroke Res       Date:  2014-02-20       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.